Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral Glutamine for Infection in Burn Patients
NCT05140772Phase 3Unknown
- Sponsor
- Menoufia University
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alanyl glutamine in burn injury, sponsored by Menoufia University. Status: unknown.
02
Drugs
alanyl glutamine
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT05140772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05140772.